Current Drug Targets
Title: Editorial [ Tachykinins and their Receptors in Human Physiology and Diseases Guest Editor: Carla Palma ]
Volume: 7Issue: 8
Author(s):Carla Palma
Affiliation:
Export Options
About this article
Cite this article as:
Palma Carla, Editorial [ Tachykinins and their Receptors in Human Physiology and Diseases Guest Editor: Carla Palma ], Current Drug Targets 2006; 7 (8) .https://dx.doi.org/10.2174/138945006778019327
DOI https://dx.doi.org/10.2174/138945006778019327 | Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher | Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
Emerging Drug Targets and Revolutionary Therapeutic Approaches for Effective Anti-Cancer Intervention
Recent advancements in cancer research have significantly advanced our understanding of the intricate molecular mechanisms driving cancer progression, leading to the identification of new drug targets and therapeutic strategies. The elucidation of complex signaling pathways and genetic aberrations associated with tumorigenesis has provided valuable insights into potential targets for intervention. ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
- Atorvastatin's Reduction of Alzheimer's Disease and Possible Alterationof Cognitive Function in Midlife as well as its Treatment
CNS & Neurological Disorders - Drug Targets Stem Cells and Bioactive Scaffolds as a Treatment for Traumatic Brain Injury
Current Stem Cell Research & Therapy Bilirubin and the Genome: The Hereditary Basis of Unconjugated Neonatal Hyperbilirubinemia
Current Pharmacogenomics Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical BiotechnologyHerbal Components for the Treatment of Alzheimer's Disease
The Natural Products JournalThe Applications of Pharmacogenomics to Neurological Disorders
Current Molecular Medicine The Changing Face of HDAC Inhibitor Depsipeptide
Current Cancer Drug TargetsMedial Temporal Lobe Volumes in Amnestic Mild Cognitive Impairment and Late-life Depression: Research Synthesis
Current Psychiatry ReviewsSkin as a Novel Route for Allergen-specific Immunotherapy
Current Pharmaceutical Design HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects
Current Pharmaceutical DesignDisturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Current Alzheimer ResearchDifferentiating Normal from Pathological Brain Ageing Using Standard Neuropsychological Tests
Current Alzheimer ResearchSoy Isoflavones and Cardiovascular Disease Epidemiological, Clinical and -Omics Perspectives
Current Pharmaceutical Biotechnology Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas
Current Pharmaceutical DesignAdeno-Associated Virus Vectors: Immunobiology and Potential Use for Immune Modulation
Current Gene Therapy The Neurotrophins and Their Role in Alzheimers Disease
Current Neuropharmacology Editorial [Hot Topic: When Can a Drug be Declared “Safe”? (Guest Editors: Frank M.C. Besag & Seetal Dodd)]
Current Drug SafetyMachine-Based Learning Shifting to Prediction Model of DeteriorativeMCI Due to Alzheimer’s Disease - A Two-Year Follow-Up Investigation
Current Alzheimer ResearchPast Efforts and Future Prospects for a Nasal Influenza Vaccine
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)Photosensitizers Mediated Photodynamic Inactivation Against Virus Particles
Mini-Reviews in Medicinal Chemistry
[8]ページ先頭